Tempus AI (NASDAQ:TEM) Earns Buy Rating from Analysts at TD Cowen

TD Cowen assumed coverage on shares of Tempus AI (NASDAQ:TEM) in a research report released on Tuesday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $50.00 price objective on the stock.

Several other brokerages have also recently issued reports on TEM. Loop Capital assumed coverage on shares of Tempus AI in a report on Tuesday. They set a buy rating and a $48.00 target price for the company. JPMorgan Chase & Co. started coverage on Tempus AI in a research note on Tuesday. They set an overweight rating and a $42.00 price objective for the company. Nine investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, Tempus AI has a consensus rating of Buy and an average target price of $45.63.

Tempus AI Stock Up 7.1 %

Shares of NASDAQ TEM opened at $37.50 on Tuesday. Tempus AI has a 52 week low of $22.89 and a 52 week high of $43.88.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.